Cite

HARVARD Citation

    Ray, K. et al. (2022). Obicetrapib lowers LDL-C in patients on high intensity statins: Results from the rose trial (NCT04753606). Atherosclerosis. pp. 11-12. [Online]. 
  
Back to record